Literature DB >> 26406380

SnapShot: CRISPR-RNA-guided adaptive immune systems.

Joshua Carter1, Blake Wiedenheft1.   

Abstract

Bacteria and archaea have evolved sophisticated adaptive immune systems that reply on CRISPR loci and a diverse cassette of Cas genes that are classified into three main types and at least eleven subtypes. All CRISPR-Cas immune systems operate through three main stages: acquisition, biogenesis, and interference. This SnapShot summarizes our current knowledge of these fascinating immune systems.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26406380      PMCID: PMC4668126          DOI: 10.1016/j.cell.2015.09.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  10 in total

1.  Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system.

Authors:  Kirill A Datsenko; Ksenia Pougach; Anton Tikhonov; Barry L Wanner; Konstantin Severinov; Ekaterina Semenova
Journal:  Nat Commun       Date:  2012-07-10       Impact factor: 14.919

Review 2.  CRISPR-mediated adaptive immune systems in bacteria and archaea.

Authors:  Rotem Sorek; C Martin Lawrence; Blake Wiedenheft
Journal:  Annu Rev Biochem       Date:  2013-03-11       Impact factor: 23.643

Review 3.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 4.  Evolution and classification of the CRISPR-Cas systems.

Authors:  Kira S Makarova; Daniel H Haft; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Yuri I Wolf; Alexander F Yakunin; John van der Oost; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2011-05-09       Impact factor: 60.633

Review 5.  A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

Authors:  Ryan N Jackson; Blake Wiedenheft
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

6.  Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.

Authors:  Joseph Bondy-Denomy; Bianca Garcia; Scott Strum; Mingjian Du; MaryClare F Rollins; Yurima Hidalgo-Reyes; Blake Wiedenheft; Karen L Maxwell; Alan R Davidson
Journal:  Nature       Date:  2015-09-23       Impact factor: 49.962

7.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.

Authors:  Poulami Samai; Nora Pyenson; Wenyan Jiang; Gregory W Goldberg; Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

8.  Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation.

Authors:  Yunzhou Wei; Rebecca M Terns; Michael P Terns
Journal:  Genes Dev       Date:  2015-02-15       Impact factor: 11.361

9.  Cas9 specifies functional viral targets during CRISPR-Cas adaptation.

Authors:  Robert Heler; Poulami Samai; Joshua W Modell; Catherine Weiner; Gregory W Goldberg; David Bikard; Luciano A Marraffini
Journal:  Nature       Date:  2015-02-18       Impact factor: 49.962

10.  Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity.

Authors:  James K Nuñez; Amy S Y Lee; Alan Engelman; Jennifer A Doudna
Journal:  Nature       Date:  2015-02-18       Impact factor: 49.962

  10 in total
  3 in total

1.  Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

Authors:  MaryClare F Rollins; Saikat Chowdhury; Joshua Carter; Sarah M Golden; Royce A Wilkinson; Joseph Bondy-Denomy; Gabriel C Lander; Blake Wiedenheft
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

2.  Characterization of CRISPR RNA transcription by exploiting stranded metatranscriptomic data.

Authors:  Yuzhen Ye; Quan Zhang
Journal:  RNA       Date:  2016-05-17       Impact factor: 4.942

3.  Visualization Analysis of CRISPR Gene-editing Knowledge Map based on Citespace.

Authors:  Rui Wang; Lin Zhang; Changwu Yue
Journal:  Biol Bull Russ Acad Sci       Date:  2021-12-17       Impact factor: 0.392

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.